The United States Securities and Exchange Commission (SEC) has announced the effectiveness of a Form F-1 for TC BioPharm (Holdings) plc. The notice indicates that the form became effective on August 28, 2024, at 4:00 P.M. This form is typically used by foreign private issuers to register their securities for sale in the United States. The effectiveness of this form signifies that TC BioPharm (Holdings) plc has met the necessary SEC requirements to proceed with the sale of its securities.

The United States Securities and Exchange Commission (SEC) has announced the effectiveness of a Form F-1 for TC BioPharm (Holdings) plc. The notice indicates that the form became effective on August 28, 2024, at 4:00 P.M. This form is typically used by foreign private issuers to register their securities for sale in the United States. The effectiveness of this form signifies that TC BioPharm (Holdings) plc has met the necessary SEC requirements to proceed with the sale of its securities.